insights_auto
Outlook: 75.0% bullish·0.0% bearish
Go to analysischevron_right
INCY:NASDAQ
Incyte Corp
$113.25
arrow_upward
+0.16%(+0.18) 1D
$113.36
arrow_upward
+0.10% (+0.11)bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$113.19
High
$114.38
Low
$112.71
Mkt. cap
22.96B
Avg. vol.
1.69M
Volume
1.19M
P/E ratio
14.43
52-wk high
$132.58
52-wk low
$84.02
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
Open
$113.19
High
$114.38
Low
$112.71
Mkt. cap
22.96B
Avg. vol.
1.69M
Volume
1.19M
P/E ratio
14.43
52-wk high
$132.58
52-wk low
$84.02
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
www.marketscreener.com
·
23 minutes ago
Incyte Insider Sold Shares Worth $297,780, According to a Recent SEC Filing
Simply Wall Street
·
15 hours ago
Should ESMO 2026 Cancer Data Require Action From Incyte Stock Investors?
GuruFocus
·
21 hours ago
Incyte (INCY) to Present New Oncology Data at ESMO Congress 2026
MyChesCo
·
1 day ago
Incyte Sets October 29 Date for Third-Quarter Earnings
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com